LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA
Clinical trials for LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could shrink rare bladder tumors without surgery
Disease control Recruiting nowThis study tests a new drug called dabogratinib (TYRA-300) in 230 adults with a rare, low-grade cancer in the upper urinary tract. The goal is to see if the drug can make tumors disappear completely within 6 months. Participants take the drug by mouth and are monitored for safety…
Matched conditions: LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated May 17, 2026 08:50 UTC
-
New gene therapy dripped into kidney aims to fight low-grade cancer
Disease control Recruiting nowThis early-stage trial tests a gene therapy drug (nadofaragene firadenovec) that is instilled directly into the kidney's drainage system. It aims to treat low-grade upper tract urothelial cancer without major surgery. About 20 adults with confirmed low-grade tumors will receive t…
Matched conditions: LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Ferring Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:56 UTC